Shengyu Mu

1.4k total citations
39 papers, 1.1k citations indexed

About

Shengyu Mu is a scholar working on Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Shengyu Mu has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nutrition and Dietetics, 13 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Molecular Biology. Recurrent topics in Shengyu Mu's work include Sodium Intake and Health (12 papers), Hormonal Regulation and Hypertension (11 papers) and Ion Transport and Channel Regulation (6 papers). Shengyu Mu is often cited by papers focused on Sodium Intake and Health (12 papers), Hormonal Regulation and Hypertension (11 papers) and Ion Transport and Channel Regulation (6 papers). Shengyu Mu collaborates with scholars based in United States, Japan and China. Shengyu Mu's co-authors include Toshiro Fujita, Tatsuo Shimosawa, Yutaka Yatomi, Fumiko Kawakami-Mori, Sayoko Ogura, Yuzaburo Uetake, Hong Wang, Daigoro Hirohama, Hirotoshi Tanaka and Takeshi Marumo and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Shengyu Mu

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Shengyu Mu

Since Specialization

Citations

This map shows the geographic impact of Shengyu Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyu Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyu Mu more than expected).

Fields of papers citing papers by Shengyu Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyu Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyu Mu. The network helps show where Shengyu Mu may publish in the future.

Co-authorship network of co-authors of Shengyu Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyu Mu. A scholar is included among the top collaborators of Shengyu Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyu Mu. Shengyu Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BPDE induces ferroptosis in hippocampal neurons through ACSL3 suppression 2025 ·NeuroToxicology ·(unknown), (unknown), (unknown), Fengjie Tian, (unknown), Shengyu Mu, Jinping Zheng	3
2	Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury 2024 ·Journal of Neuroinflammation ·Rami Ahmad Shahror, Esraa Shosha, Carol Morris, (unknown), Shengyu Mu, Gábor Csányi, Marjan Boerma, Nancy J. Rusch, Abdelrahman Y. Fouda	7
3	The link between immunity and hypertension in the kidney and heart 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Shengyu Mu	9
4	Mitochondrial proton leak in cardiac aging 2023 ·GeroScience ·Xingyun Qi, Nancy J. Rusch, Jiaojiao Fan, (unknown), Lixin Xie, Shengyu Mu, Peter S. Rabinovitch, Huiliang Zhang	6
5	Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Shengyu Mu, Lee Ann MacMillan-Crow, Paul L. Prather	1
6	Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target 2022 ·Journal of Cellular and Molecular Medicine ·Jungang Chen, (unknown), Zhen Lin, Samantha Kendrick, Shengyu Mu, Lu Dai, Zhiqiang Qin	8
7	Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), Shengyu Mu, Nancy J. Rusch, (unknown)	6
8	Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients 2022 ·Frontiers in Microbiology ·Lu Dai, Yong‐Chen Lu, Jungang Chen, (unknown), Shengyu Mu, J. Craig Forrest, Denise Whitby, Steven R. Post, Zhiqiang Qin	2
9	Dantrolene Prevents the Lymphostasis Caused by Doxorubicin in the Rat Mesenteric Circulation 2021 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), Vijayalakshmi Sridharan, Shengyu Mu, Nancy J. Rusch, (unknown)	7
10	Eplerenone Attenuates Fibrosis in the Contralateral Kidney of UUO Rats by Preventing Macrophage-to-Myofibroblast Transition 2021 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), Cuijuan Zhang, Fan Yang, Zheng Wang, (unknown), Xiangting Wang, Shengyu Mu, (unknown)	31
11	KATP Channel Openers Inhibit Lymphatic Contractions and Lymph Flow as a Possible Mechanism of Peripheral Edema 2020 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Daniel J. Stuckey, Mustafa Sarimollaoglu, (unknown), Philip Palade, Nancy J. Rusch, Shengyu Mu	14
12	Vascular smooth muscle TRPC3 channels facilitate the inverse hemodynamic response during status epilepticus 2020 ·Scientific Reports ·(unknown), Kevin D. Phelan, Hong Wu, Shengyu Mu, Lutz Birnbaumer, Nancy J. Rusch, Fang Zheng	12
13	NLRP3 inflammasome via IL-1β regulates PCSK9 secretion 2020 ·Theranostics ·Zufeng Ding, Xianwei Wang, Shijie Liu, Sichang Zhou, Rajshekhar A. Kore, Shengyu Mu, Xiaoyan Deng, Yubo Fan, Jawahar L. Mehta	60
14	Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG) 2020 ·Journal of Cancer ·Lu Dai, (unknown), Zhen Lin, (unknown), Shengyu Mu, Zhiqiang Qin	5
15	Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines 2019 ·Cardiovascular Research ·Shijie Liu, Xiaoyan Deng, Peng Zhang, Xianwei Wang, Yubo Fan, Sichang Zhou, Shengyu Mu, Jawahar L. Mehta, Zufeng Ding	63
16	Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome 2017 ·Frontiers in Pharmacology ·Clark Sims, Sharda P. Singh, Shengyu Mu, Neriman Gökden, (unknown), Trung C. Nguyen, Philip R. Mayeux	14
17	CD8+ T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension 2017 ·Nature Communications ·(unknown), Tonya Rafferty, Sung W. Rhee, Jessica Webber, Li Song, Benjamin Ko, Robert S. Hoover, (unknown), Shengyu Mu	74
18	High Salt Intake and Hypertension 2012 ·KAGAKU TO SEIBUTSU ·Tatsuo Shimosawa, Shengyu Mu, Toshiro Fujita	1
19	The Kidney and Hypertension: Pathogenesis of Salt-Sensitive Hypertension 2012 ·Current Hypertension Reports ·Tatsuo Shimosawa, Shengyu Mu, Shigeru Shibata, Toshiro Fujita	7
20	Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor–dependent pathway 2011 ·Journal of Clinical Investigation ·Shigeru Shibata, Shengyu Mu, Hiroo Kawarazaki, Kazuhiko Muraoka, Kenichi Ishizawa, Shigetaka Yoshida, Wakako Kawarazaki, Maki Takeuchi, Nobuhiro Ayuzawa, Jun Miyoshi, Yoshimi Takai, (unknown), Tatsuo Shimosawa, Katsuyuki Ando, Miki Nagase, Toshiro Fujita	192

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact